Real-time enrollment status for this pulmonary arterial hypertension clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 12:21 PM UTC
| NCT Number | NCT07218029 |
| Recruiting Status | Recruiting |
| Condition | Pulmonary Arterial Hypertension |
| Phase | PHASE3 |
| Target Enrollment | 815 participants |
| Active Locations | 35 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | August 21, 2026 (6 days ago) |
As of August 27, 2026: Clinical trial NCT07218029 is currently recruiting participants. This phase3 study for pulmonary arterial hypertension is actively seeking new participants at 35 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07218029 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 35 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07218029 was last updated 6 days ago (August 21, 2026). HelloStudys verifies this status automatically.